TrialLeukemia2018

Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL.

J R Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.